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Abstract
Rationale: During exercise, heart failure patients (HF) show an out-of-proportion ventilation increase, which in patients with
COPD is blunted. When HF and COPD coexist, the ventilatory response to exercise is unpredictable.
Objectives:We evaluated a human model of respiratory impairment in 10 COPD-free HF patients and in 10 healthy subjects,
tested with a progressive workload exercise with different added dead space. We hypothesized that increased serial dead
space upshifts the VE vs. VCO2 relationship and that the VE-axis intercept might be an index of dead space ventilation.
Measurements: All participants performed a cardiopulmonary exercise test with 0, 250 and 500 mL of additional dead
space. Since DS does not contribute to gas exchange, ventilation relative to dead space is ventilation at VCO2 = 0, i.e. VE-axis
intercept. We compared dead space volume, estimated dividing VE-axis intercept by the intercept on respiratory rate axis of
the respiratory rate vs. VCO2 relationship with standard method measured DS.
Main results: In HF, adding dead space increased VE-axis intercept (+0 mL= 4.9861.63 L; +250 mL= 9.6962.91 L;
+500 mL= 13.2663.18 L; p,0.001) and upshifted the VE vs.VCO2 relationship, with a minor slope rise (+0 mL= 2764 L;
+250 = 2865; +500 = 2964; p,0.05). In healthy, adding dead space increased VE-axis intercept (+0 mL= 4.961.4 L;
+250 = 9.362.4; +500= 13.163.04; p,0.001) without slope changes. Measured and estimated dead space volumes were
similar both in HF and healthy subjects.
Conclusions: VE-axis intercept is related to dead space ventilation and dead space volume can be non-invasively estimated.
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Introduction
The behaviour of ventilation during exercise in heart failure
(HF) and in chronic obstructive pulmonary disease (COPD)
patients may differ, being characterized in the former by an out-of-
proportion increase of ventilation (VE), which is greater the
greater the HF severity [1] and, in the latter, by a normal or
excessive increase of ventilation in mild or moderate COPD and a
blunted ventilation increase in severe COPD patients [2–4]. The
elevated ventilatory response in HF patients seen before lactic
acidosis ensues and the carbon dioxide (CO2) [5] generated by the
lactate is trivial relative to the rate of metabolic CO2 production
(VCO2) [6,7]. The relationship between VE and VCO2 is used to
evaluate ventilatory efficiency [8]; in HF, as well as in pulmonary
arterial hypertension, an increase of the slope of the VE vs. VCO2
relationship is associated with a poor prognosis [9–16]. In COPD,
ventilatory limitation to exercise is defined either as a reduction of
ventilatory reserve or as a lowering of inspiratory capacity [17]. In
case of severe COPD, the rise of ventilation during exercise is
blunted, and consequently the slope of VE vs. VCO2 relationship
is normal or low, being the slope lower the more pronounced the
emphysema profile [2].
HF and COPD often coexist with a reported prevalence of
COPD in HF patients ranging between 23 and 30% [18] and with
a relevant impact on mortality and hospitalization rates [19]. In
patients with COPD and HF, the ventilatory response to exercise
is poorly predictable. Indeed, HF hyperventilation can be
counteracted by the incapacity of increasing tidal volume (VT)
and alveolar ventilation, both being distinctive features of VE
during exercise in COPD patients [17]. As a result, the slope of VE
vs.VCO2 relationship might be elevated, normal or even low in
patients with COPD and HF, regardless of the presence and of the
severity of ventilatory inefficiency. Up to now, only few studies
have evaluated the ventilatory behaviour during exercise in
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patients with coexisting HF and COPD, being patients with
comorbidities usually excluded from research trials dedicated to
HF or COPD [20].
In the present study, we evaluated HF patients and healthy
individuals through a progressive workload exercise with different
added DS, hoping to mimic at least in part the effects of COPD on
ventilation behaviour during exercise. We hypothesized that
increased serial DS upshifts the VE vs. VCO2 relationship and
that the VE-axis intercept (VEYinter) might be an index of DS
ventilation. Indeed, since DS does not contribute to gas exchange,
VE relative to DS is VE at VCO2=0, i.e., VEYint on the VE vs.
VCO2 relationship.
Methods
Subjects
Ten HF patients and 10 healthy subjects were enrolled in the
present study.
HF patients were regularly followed-up at our HF unit. Study
inclusion criteria for HF patients were New York Heart
Association functional classes (NYHA) I to III, echocardiographic
evidence of reduced left ventricular systolic function (left ventric-
ular ejection fraction #40%), optimized and individually tailored
drug treatment, stable clinical conditions for at least 2 months,
capability/willingness to perform a maximal or near maximal
cardiopulmonary exercise test (CPET). Patients were excluded if
they had obstructive and/or restrictive lung disease (forced
expiratory volume in first second/forced vital capacity ratio
(FEV1/FVC) ,0.70% and/or lung vital capacity (VC) ,80% of
predicted value [21]), clinical history and/or documentation of
pulmonary embolism, primary valvular heart disease, pulmonary
artery hypertension, pericardial disease, exercise-induced angina,
ST changes, severe arrhythmias and significant cerebrovascular,
renal, hepatic and haematological disease.
A group of age matched healthy subjects was recruited among
the hospital staff and from the local community through personal
contacts. Inclusion criteria were absence of history and/or clinical
evidence of any cardiovascular or pulmonary or systemic disease
contraindicating the test or modifying the functional response to
exercise, any condition requiring daily medications, and the
inability to adequately perform the procedures required by the
protocol. No subjects were involved in physical activities other
than recreational.
The investigation was approved by the local ethics committee
(‘‘Ethics committee Centro Cardiologico Fondazione Monzino’’,
Institutional Review Board no. S186/311) and all participants
signed a written informed consent before enrolling in the study.
Study protocol
At enrolment, demographical and clinical data were collected,
lung function measurements and echocardiographic evaluation
were performed to verify that the subjects screened met the study
inclusion/exclusion criteria, and the informed consent was
obtained.
Spirometry (Vmax 29C, SensorMedics, Yorba Linda, CA, US)
was performed by all participants in accordance with the
recommended technique [22], and measurements were standard-
ized as percentages of predicted normal values [23].
To become familiar with the procedure, both HF patients and
healthy subjects had been previously trained to perform an
exercise test in our laboratory [24]. Thereafter, on different days,
following a random order, exercise testing was done with
additional DS equal to 0 mL, 250 mL and 500 mL.
All participants underwent incremental CPET on an electron-
ically braked cycle-ergometer (Ergometrics-800, SensorMedics,
Yorba Linda, CA, US) using a personalized ramp protocol that
was chosen aiming at a test duration of 1062 minutes. The
exercise was preceded by 5 minutes of rest gas exchange
monitoring and by a 3-minute unloaded warm-up. A 12-lead
ECG, blood pressure and heart rate were also recorded, and
arterial oxygen saturation was monitored through a pulse
oxymeter. The participants wore a nose clip and breathed through
a mouthpiece connected to a mass flowmeter (Vmax 29C,
SensorMedics, Yorba Linda, CA, US). Subjects were asked to
cycle at a pedalling rate of 60–70 rpm, and CPET were self-
terminated by the subjects when they claimed that maximal effort
had been achieved. Oxygen consumption (VO2), VCO2 and VE
were measured breath by breath with flowmeter and respiratory
gas sampling lines at the end of the added DS. They were
averaged every 20 seconds. Anaerobic threshold (AT) was
calculated with the standard technique [25]. All tests were
executed and evaluated by 2 expert readers.
In the absence of psychogenic hyperventilation, below the
respiratory compensation point [26], the relation between VE and
VCO2 is characterized by a linear relationship (VE= aVCO2+ b),
with ‘‘a’’ as the slope and ‘‘b’’ as the intercept on the VE axis
(VEYint) [8]. Since DS does not contribute to gas exchange, it is
possible to hypothesize that the ventilation relative to DS is similar
or related to the VE at VCO2= 0, which is the Y intercept of VE
vs. VCO2 relationship. To calculate DS volume (VD) from VEYint
(VDYint), we need to identify the corresponding respiratory rate
(RR). This was obtained as the intercept of the RR vs. VCO2
relationship on the RR axis (RRYint). Specifically, the RR vs.
VCO2 relationship was calculated through its linear portion that
starts from the beginning of exercise and ends when RR increases
more steeply, which corresponds to the tidal volume inflection/
plateau [27,28]. An example on how we calculate VEYint and
RRYint is reported in figure 1.
We compared estimated VD values (VDYint) with resting and
exercise values of VD, measured with standard method [8]
(VDmeas), in the 3 experimental conditions, with 0 mL, 250 mL
and 500 mL of added DS. The volume of mouthpiece and
flowmeter (50 mL) was subtracted from VD. The standard
calculation of VD [8] (VDmeas) is obtained by the following
equation:
VD~VT 1  863  VCO2ð Þ= VE  PaCO2ð Þ½ 
with 863 as a constant and PaCO2 as pressure for arterial CO2.
In healthy individuals [29], but not in HF patients [30], PaCO2
can be reliably estimated from end-tidal expiratory pressure for
CO2 (PETCO2). Therefore, we measured PaCO2 from arterial gas
sampling in HF patients, and we estimated PaCO2 from PETCO2
in healthy subjects. Thus, only in HF patients, a small catheter was
introduced into a radial artery, blood samples were obtained at
rest and every 2 minutes during exercise, and PaCO2 was
determined with a pH/blood gas analyzer (GEM 4000, Instru-
mentation Laboratory, Bedford, MA, US).
We calculated possible VD changes during exercise, and we
evaluated whether an added DS modifies the slope of the VE vs.
VCO2 relationship and/or it simply upshifts it.
Statistical analysis
Data are mean 6 standard deviation (SD). Cardiopulmonary
measurements were collected breath by breath and reported as
average over 20 s. Comparisons between the two groups were
done through unpaired t-test. Both in HF and in healthy subjects,
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analysis of variance for repeated measures with Bonferroni post
hoc test was performed to analyze the effect of the adding of
different DS and to evaluate the changes of VDmeas during
exercise in the 3 experimental conditions. Bland and Altman
relationship was calculated to compare VDYint values and VDmeas
values in HF patients and in healthy individuals.
Statistical significance was set at p,0.05. All statistics were
performed with IBM SPSS statistics 20.0 for windows.
Results
We enrolled 10 HF patients (9 males; mean age 61613 years)
and 10 age-matched healthy subjects (8 males; mean age 59610
years). The main anthropometric data were not significantly
different between the two groups. Patients with HF and healthy
subjects were free from obstructive defects; although within the
predicted normal limits, lung volumes tended to be smaller in HF
patients than in normal subjects (table 1).
HF patients
Mean left ventricle ejection fraction was 3365%. The cause of
HF was ischemic dilated cardiomyopathy in 4 cases and primary
dilated cardiomyopathy in 6 cases. Three patients had an
implantable cardioverter defibrillator; 9 were in sinus rhythm
and 1 was in permanent atrial fibrillation. Four patients were in
NYHA class I, 5 in NYHA class II and 1 in NYHA class III. All
HF patients were on b-blockers, 9 with angiotensin-converting
enzyme inhibitors, 4 with aldosterone receptor antagonists, 5 with
diuretics and 3 with amiodarone.
All HF patients performed CPET without added DS and with
250 mL and 500 mL of additional DS without complications. In
the HF group, peak VO2 was slightly reduced compared to
healthy subjects. With the exception of reduced peak workload
and of an increased VT, the adding of different DS did not
significantly impact on CPET data at peak of exercise and on VO2
at AT (table 2). In table 3 VE, RR, VT, VD/VT, VCO2, PETCO2
and PaCO2 during exercise are reported with 0, 250 and 500 mL
of added DS.
Values of VEYint, RRYint, VDYint, VDmeas and the slope of VE
vs VCO2 relationship in HF patients with 0 mL, 250 mL and
500 mL of additional DS are reported in table 4.
With the adding of DS, the VEYint increased significantly,
whereas RRYint showed a limited increase. Adding DS upshifted
the VE vs. VCO2 relationship with a minor slope increase
(figure 2).
The calculated VDYint rose as added DS increased; mean
VDYint increase with 250 and 500 mL of added space was
2266127 mL and 4466123 mL. VDmeas increased during
exercise in the 3 conditions albeit only as a trend when DS was
not added (table 5).
Figure 3 reports the Bland and Altman plot of VDYint vs.
VDmeas at rest for HF patients in the 3 exercise conditions. As an
average, a good agreement was observed when VD was calculated
either by VEYint, or VDmeas, with or without additional DS.
Healthy subjects
Healthy subjects performed all CPET without complications.
Peak exercise data and VO2 at AT were not significantly affected
by the adding of DS (table 2).
When DS was added, the value of the slope of VE vs. VCO2
relationship and RRYint did not change, whereas only the VEYint
increased significantly (table 4) with an upshift of the relationship
(figure 4). Similarly to HF patients, VDYint increased with added
DS in the three experimental conditions, specifically by
3006150 mL and by 5706160 mL with 250 and 500 mL,
respectively.
During exercise, VDmeas remained constant without additional
DS, whereas it significantly decreased during exercise with added
DS, but this finding is likely due to the underestimation of PaCO2
by PETCO2 with added DS (table 5).
Figure 5 reports the Bland and Altman plot of VDYint vs.
VDmeas at rest for healthy subjects and showed a good correlation
between the two methods both with and without additional DS.
Discussion
In the present study, we evaluated a human model of increased
dead space in HF patients and in healthy subjects, applying a
progressive workload exercise with different added DS. We
documented that a rise in serial DS, mimicking a rise in
anatomical DS, was parallel to the VEYint increase both in healthy
individuals and in HF patients. Therefore, VEYint is related to DS
ventilation. Moreover, we showed that the value of DS can be
non-invasively estimated as the ratio of VEYint/RRYint.
Few study limitations should be discussed at first. Firstly, our
research was undertaken to analyze the role on ventilation
behaviour during exercise of a respiratory comorbidity, COPD,
in HF patients. We built a COPD model by adding an external
dead space. We recognize that our model is only a partial COPD
Figure 1. VE vs. VCO2 relationship in a patient. The relationship is
linear up to the respiratory compensation point (end of the isocapnic
buffering period) (Upper panel). RR vs. VCO2 relationship. The
relationship is calculated as for VE vs. VCO2 (Lower panel).
doi:10.1371/journal.pone.0087395.g001
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model because we have not considered any of the systemic
consequences of COPD and we have limited our attention to DS
changes. Our model was over-simplistic also as regards lung
mechanics because an artificial dead space increase does not
generate air trapping which is one of the most characteristic
features of COPD during exercise. Secondly, our model was short
lasting, so that chronic ventilatory and chemoreceptor adaptations
to increased DS were not evaluated as were not evaluated
Table 1. Main anthropometric characteristics, demographical and pulmonary function data of heart failure patients and healthy
subjects enrolled in the study.
HEART FAILURE PATIENTS HEALTHY SUBJECTS p value
Number 10 10 NS
Male/female 9/1 8/2 NS
Age (yr) 61612 5967 NS
Height (cm) 17269 17366 NS
Weight (Kg) 85615 77611 NS
BMI (Kg/m2) 28.663.8 25.463.2 NS
VC (L) 3.5860.75 4.7261.03 ,0.01
VC (% predicted) 91614 112613 ,0.01
FVC (L) 3.4760.67 4.6361.10 ,0.01
FVC (% predicted) 90612 112614 ,0.01
FEV1 (L) 2.5660.58 3.5760.84 ,0.001
FEV1 (% predicted) 79614 107617 ,0.001
FEV1/FVC 7364 7665 NS
Data are presented as number or mean6 SD. BMI= body mass index; NS= not significant; FEV1= forced expiratory volume in 1 s; FVC = forced vital capacity; VC=
vital capacity.
doi:10.1371/journal.pone.0087395.t001
Table 2. Cardiopulmonary exercise testing data in heart failure patients (upper panel) and healthy subjects (lower panel) with
0 mL, 250 mL and 500 mL of additional dead space.
HEART FAILURE PATIENTS ADDED DEAD SPACE ANOVA p value
+0 mL +250 mL +500 mL
Peak workload (W) 109641* 103647 96641 0.006
Peak VO2 (mL/min/Kg) 19.965.8 19.365.6 19.665 NS
VO2 at AT (mL/min/Kg) 1363 14.164 12.765.8 NS
Peak O2 pulse (mL/beat) 15.865.7 15.465.2 15.764.8 NS
Peak HR (beat/min) 111626 110628 104620 NS
Peak VT (L) 1.960.49 1.9360.49
$ 2.0960.59 0.047
Peak VE (L/min) 55.6614 59.8614 58.8611 NS
Peak RR (bpm) 3064 3165 3065 NS
Peak PaO2 (mmHg) 107612 104616 100620 NS
Peak SaO2 (L/min) 98.461.2 97.561.9 97.761.7 NS
HEALTHY SUBJECTS
Peak workload (W) 200651 195651 189645 NS
Peak VO2 (mL/min/Kg) 36.168.4 35.667.2 35.867.5 NS
VO2 at AT (mL/min/Kg) 21.765.7 23.663.7 25.366.6 NS
Peak O2 pulse (mL/beat) 17.564.2 1762.9 18.463.4 NS
Peak HR (beat/min) 156618 157618 156618 NS
Peak VT (L) 2.7160.6 2.5760.9 2.9560.5 NS
Peak VE (L/min) 88.6621.9 87.2616.2 88.6617.1 NS
Peak RR (bpm) 3264 3266 3065 NS
Data are presented as means 6 SD; AT= anaerobic threshold; bpm= breaths per minute; HR=heart rate; NS= not significant; PaO2= arterial oxygen pressure;
RR= respiratory rate; SaO2 = arterial oxygen saturation; RR= respiratory rate; VO2=oxygen consumption; VE= ventilation; VT= tidal volume; W=watt.
$
p,0.05 versus +500 mL; * p,0.01 versus +500 mL.
doi:10.1371/journal.pone.0087395.t002
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primitive chemoreceptor abnormalities as drivers of the alveolar
hypoventilation observed in COPD patients. Thirdly, with the Y-
intercept we analyze an index of overall DS. However, in the
present setting, we were able to change DS only by adding an
external (anatomical equivalent) DS, so that we do not know if
changes in physiological DS similarly influence the VEYint.
Fourthly, VE changes during exercise are due to VCO2, VD/
VT and PaCO2 changes, and all may influence the VE vs. VCO2
relationship. In the present study, we added external DS, which at
each step of exercise, was associated to an increase of VD/VT and
PaCO2 (the latter in 2 steps only as a trend) resembling what
happens during exercise in COPD patients (table 3). Therefore
both PaCO2 and VD/VT changes have likely a role in the VE vs.
VCO2 relationship changes we observed after adding DS. It is
recognized that PaCO2 measurements were done only in HF
patients and not in healthy subjects, but a different behaviour in
healthy subjects is unlikely. Fifthly, the condition of VE at CO2
production equal 0, as such at the VEYint of the VE vs. VCO2
relationship, is a mathematical extrapolation with no physiological
meaning. Moreover, absolute DS changes during exercise, so that
also the VEYint value is likely close but different from the rest
value. Indeed, we showed that VD tended to increase in HF
patients and to reduce in healthy subjects during exercise without
added DS. However, we suggest using VEYint as a tool to evaluate
the presence of an increased DS, regardless of its physiological
meaning with respect to rest and exercise. The adding of DS
significantly reduced the external work produced in HF patients,
while a not significant reduction was observed in normal subjects.
Peak VO2 remained unchanged in both groups after adding DS;
this finding suggests that added DS was associated to an increased
work of breathing which, as a percentage of total work, seems to be
greater in HF patients than in normal subjects.
Table 3. Ventilatory parameters in heart failure patients with 0, 250 and 500 mL of additional dead space.
HF PATIENTS +0 mL +250 mL +500 mL ANOVA p value
Rest
VE (L/min) 11.8 6 1.7
$m 16.2 6 3.5 20.0 6 4.2 ,0.001
RR (bpm) 14.2 6 2.0 16.4 6 4.1 16.8 6 3.1 NS
VT (L) 0.8 6 0.2* 1.0 6 0.2£ 1.2 6 0.1 ,0.001
VD/VT 0.47 6 0.15$& 0.61 6 0.10 0.67 6 0.11 ,0.001
VCO2 (L/min) 0.25 6 0.06 0.29 6 0.13 0.29 6 0.14 NS
PETCO2 (mmHg) 33.4 6 1.6 33.0 6 2.5 33.1 6 4.2 NS
PaCO2 (mmHg) 35.8 6 2.2
$m 38.6 6 1.9 39.9 6 2.02 ,0.001
4 min exercise
VE (L/min) 21.6 6 3.8m# 30.2 6 5.0 34.8 6 4.3 ,0.001
RR (bpm) 18.7 6 2.7 20.4 6 4.3 20.7 6 4.1 NS
VT (L) 1.2 6 0.2& 1.5 6 0.3 1.7 6 0.3 ,0.001
VD/VT 0.33 6 0.09$m 0.45 6 0.06 0.54 6 0.10 ,0.001
VCO2 (L/min) 0.64 6 0.15 0.74 6 0.17 0.73 6 0.21 NS
PETCO2 (mmHg) 37.2 6 2.9 35.7 6 3.6 37.4 6 4.2 NS
PaCO2 (mmHg) 38.4 6 2.8 38.8 6 3.4 41.2 6 3.9 NS
8 min exercise
VE (L/min) 39.9 6 5.9m 44.5 6 4.8£ 52.4 6 8.4 ,0.001
RR (bpm) 25.1 6 3.2 25.3 6 5.2 26.8 6 4.6 NS
VT (L) 1.6 6 0.3 1.8 6 0.4 2.0 6 0.5 NS
VD/VT 0.28 6 0.06m# 0.41 6 0.07 0.46 6 0.09 ,0.001
VCO2 (L/min) 1.28 6 0.35 1.27 6 0.29 1.34 6 0.35 NS
PETCO2 (mmHg) 37.2 6 4.3 36.8 6 4.6 38.5 6 4.2 NS
PaCO2 (mmHg) 38.0 6 3.7 39.4 6 4.2 41.4 6 4.6 NS
peak exercise
VE (L/min) 55.7 6 14.0 59.9 6 14.6 58.9 6 11.3 NS
RR (bpm) 30.3 6 4.7 31.4 6 4.0 29.8 6 5.0 NS
VT (L) 1.9 6 0.5 1.9 6 0.5 2.1 6 0.6 NS
VD/VT 0.26 6 0.11*m 0.39 6 0.10 0.45 6 0.11 ,0.001
VCO2 (L/min) 1.81 6 0.67 1.72 6 0.68 1.58 6 0.55 NS
PETCO2 (mmHg) 35.4 6 4.5 35.646 4.8 39.0 6 4.9 NS
PaCO2 (mmHg) 35.8 6 3.8 38.0 6 4.2 41.3 6 5.5 0.049
Data are presented as means 6 SD; VE= ventilation; RR= respiratory rate; VT= tidal volume; VD=dead space volume; VCO2= carbon dioxide production; PaCO2=
arterial carbon dioxide pressure; PETCO2= End-tidal carbon dioxide pressure; bpm= breaths per minute;
$
: p,0.05 vs. 250 mL; m: p,0.001 vs. 500 mL; *: p,0.001 vs. 250 mL; &: p,0.01 vs.500 mL; #,0.01 vs. 250 mL.
doi:10.1371/journal.pone.0087395.t003
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Table 4. Values of the slope of VE vs VCO2 relationship, VEYint, RRYint and volume of dead space in heart failure patients (upper
panel) and healthy subjects (lower panel) with 0 mL, 250 mL and 500 mL of additional dead space.
HEART FAILURE PATIENTS ADDED DEAD SPACE ANOVA p value
+0 mL +250 mL +500 mL
VE/VCO2 slope 2764 2865 2964 0.037
VEYint (L/min) 4.9861.63
{1 9.6962.91* 13.2663.18 0.000
RRYint (bpm) 1364&
$ 1563 1663 0.032
VDYint (L) 0.3960.07
1 0.6160.121 0.8360.11 0.000
VDmeas (L) 0.3860.08
1 0.6160.121 0.8060.09 0.000
HEALTHY SUBJECTS
VE/VCO2 slope 2363 2464 2464 NS
VEYint (L/min) 4.961.4
{1 9.362.41 13.163.04 0.000
RRYint (bpm) 1464 1464 1463 NS
VDYint (L) 0.3760.11
1 0.6860.151 0.9560.14 0.000
VDmeas (L) 0.3760.06
1 0.6860.11* 0.9460.1 0.000
Data are presented as means 6 SD; RRYint= respiratory rate calculated as Y intercept of RR vs VCO2 relationship; VCO2= carbon dioxide production; VDYint= dead
space volume calculated as VEYint/RRYint; VDmeas= dead space volume measured by PaCO2 in heart failure patients and estimated by PETCO2 in healthy subjects; VE=
ventilation; VEYint= ventilation at VCO2 = 0, calculated as Y intercept of VE vs VCO2 relationship.
{p,0.001 versus +250 mL;
1p,0.001 versus +500 mL;
*p,0.01 versus +500 mL;
&p,0.05 versus +250 mL;
$
p,0.05 versus +500 mL;
p,0.01 versus +250 mL.
doi:10.1371/journal.pone.0087395.t004
Figure 2. VE vs. VCO2 relationship in heart failure patients with 0 mL (black line), 250 mL (grey line) and 500 mL (dotted line) of
additional dead space (DS). The adding of DS uplifts the VE vs. VCO2 relationship with a minor slope increase. { p,0.001 versus +250 mL; 1
p,0.001 versus +500 mL; * p,0.01 versus +500 mL; # p,0.05 versus other all.
doi:10.1371/journal.pone.0087395.g002
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We measured DS during exercise using a standard formula [8]
in HF patients. To avoid systemic artery catheterization, we
estimated PaCO2 from PETCO2 in healthy subjects, which is a
accepted method in the absence of lung disease [29]. It is
recognized, however, that albeit largely used in the clinical setting,
extrapolation of PaCO2 from PETCO2 even in normal individual is
approximate and likely to cause some of the variability observed
(figure 5). Moreover, the values obtained in normal subjects with
added DS showed a progressive and unrealistic DS reduction. This
is due to a PaCO2 underestimation by PETCO2 when adding DS,
confirming the need to directly measure PaCO2 during exercise for
DS evaluation [30]. The low PETCO2 compared to PaCO2
observed during exercise with added dead space (Table 3) is likely
due to the rapid rise of PCO2 during exhalation, which does not
reach a plateau.
Adding DS increased the slope of VE vs. VCO2 relationship in
HF patients but not in control subjects. This is different from what
happens in patients with severe COPD who show a high VE/
VCO2 ratio at the beginning of exercise but a blunted VE increase
during exercise, so that the slope of VE vs. VCO2 relationship is
normal or low [2]. In our model, the DS increase was too modest
to generate a ventilatory limitation to exercise, being the
ventilatory reserve at peak exercise always preserved. Accordingly,
in HF patients, but not in healthy subjects, we observed a minor
exercise performance reduction with the adding of DS.
The VE vs. VCO2 relationship is frequently used as a
prognostic tool in HF patients [9–13]. Some laboratories prefer
Table 5. Values of volume of dead space at rest and during exercise in heart failure patients and healthy subjects with no
additional dead space and with 250 mL and 500 mL of additional dead space.
+0 mL +250 mL +500 mL
HF H HF H HF H
VDmeas
rest (L)
0.38 6 0.08 0.37 6 0.06 0.61a 6 0.12 0.68¥ mH6 0.11 0.80V6 0.09 0.94r‘J£6 0.10
VDmeas 29 (L) 0.38 6 0.11 0.36 6 0.04 0.63
a 6 0.07 0.57 6 0.13 0.876 0.08 0.70 6 0.17
VDmeas 49 (L) 0.39 6 0.08 0.34 6 0.05 0.68
a 6 0.11 0.56 6 0.09 0.916 0.09 0.67 6 0.16
VDmeas 69 (L) 0.43 6 0.19 0.36 6 0.08 0.71 6 0.13 0.51 6 0.09 0.926 0.15 0.62 6 0.15
VDmeas 89 (L) 0.43 6 0.09 0.32 6 0.08 0.73
a 6 0.11 0.48 6 0.12 0.906 0.14 0.57 6 0.12
VDmeas
peak (L)
0.45 6 0.18 0.31 6 0.11 0.71 a 6 0.13 0.44 6 0.08 0.906 0.13 0.55 6 0.12
p value NS NS 0.001 0.001 0.05 0.001
Data are presented as means6 SD; DS= dead space; H= healthy subjects; HF= heart failure patients; NS= not significant; VDYint= dead space volume calculated as
VEYint/RRYint; VDmeas= dead space volume measured by PaCO2 in heart failure patients and estimated by PETCO2 in healthy subjects.
ap,0.001 versus VDmeas 69;
V p,0.05 versus VDmeas 69;
¥ p,0.05 versus VDmeas 69;
m p, 0.001 versus VDmeas 89; H p,0.01
versus VDmeas peak;
r p,0.001 versus VDmeas 29;
‘ p,0.001 versus VDmeas 49;
J p,0.001 versus VDmeas 69;
£p,0.001 versus VDmeas 89;
 p,0.001 versus VDmeas peak.
doi:10.1371/journal.pone.0087395.t005
Figure 3. Bland and Altman plot of estimated dead space (DS) volume calculated as VEYint/RRYint (VDYint) and measured DS volume
(VDmeas) at rest, calculated as (1–863/PaCO2(VE/VCO2)*VT) for heart failure patients with 0 mL (diamonds), 250 mL (circles) and
500 mL (crosses) of additional DS. The grey line identifies the mean difference of VDmeas - VDYint; the black lines identify the mean difference of
VDmeas - and VDYint61.96*standard deviation. PaCO2 = arterial carbon dioxide pressure; VE= ventilation; VT = tidal volume.
doi:10.1371/journal.pone.0087395.g003
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to analyze the ratio of the relationship [31], others the slope [32].
However, the ratio varies during exercise, so that which exercise
VE/VCO2 ratio value should be considered is still a matter of
debate [31]. Moreover, while the behaviour of VE/VCO2 ratio
during exercise is well described in normal and HF individuals
[31], its behaviour in COPD or in patients with HF and COPD is
less characteristic and not used as a diagnostics/prognostic tool.
To avoid the above-mentioned uncertainties, many authors prefer
to study the VE vs. VCO2 relationship throughout the exercise
[33] or up to the respiratory compensation point [8]. To do so, the
slope of the VE vs. VCO2 relationship is calculated, but no
attention is dedicated to the intercept of this relationship on the
VE axis. However, the increase of the slope of VE vs. VCO2
relationship may be blunted when COPD is associated to HF [2].
Notably, the presence of COPD in HF may be difficult to be
defined because some lung impairment is typical of HF and
particularly in more advanced cases regardless of COPD [5]. In
the present study, we showed that a DS increase is parallel to the
VEYint increase, so that its value should be taken into account
when analyzing the VE vs. VCO2 relationship. Indeed, VEYint
differences were observed even by adding a relatively small DS
(250 mL), which corresponded to 1/10 of peak VT in healthy
subjects. It is recognized, however, that whilst the means of
estimated and measured VD are similar, the individual values
differ up to 60% in case of no added DS and up to ,20% when
500 mL DS were added. This suggests caution when analyzing
specific individual data, particularly in the presence of no or
modest lung disease.
In the present study, we added 250 mL and 500 mL of DS
during exercise. To confirm that VEYint increase was related to DS
increase, we calculated VDYint. To do so, we need to divide VE by
RR, but the value of RR to be chosen is an open question. We
used the intercept of the RR vs. VCO2 relationship on the RR axis
because this is the RR value corresponding to VEYint. Interest-
ingly, the changes of VDYint values with added DS were very
similar to the amount of added DS.
In conclusion, we provide the rational basis for the assessment of
VEYint during exercise as a tool to evaluate DS. Further studies are
needed to confirm and to analyze the clinical meaning of the
present observation.
Figure 4. VE vs. VCO2 relationship in healthy subjects with 0 mL (black line), 250 mL (grey line) and 500 mL (dotted line) of
additional dead space (DS). The adding of DS upshifts the VE vs VCO2 relationship without significant slope changes. { p,0.001 versus +250 mL;
1 p,0.001 versus +500 mL.
doi:10.1371/journal.pone.0087395.g004
Figure 5. Bland and Altman plot of estimated dead space (DS)
volume calculated as VEYint/RRYint (VDYint) and measured DS
volume (VDmeas) at rest, calculated as (1–863/PaCO2(VE/
VCO2)*VT) with PaCO2 for healthy subjects with 0 mL (dia-
monds), 250 mL (circles) and 500 mL (crosses) of additional
DS. The grey line identifies the mean difference of VDmeas - VDYint; the
black lines identify the mean difference of VDmeas - and VDYint61.96*-
standard deviation. PaCO2 was estimated from PETCO2. PaCO2 = carbon
dioxide pressure; PETCO2 = tele-expiratory carbon dioxide pressure;
VE = ventilation; VT = tidal volume.
doi:10.1371/journal.pone.0087395.g005
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At a Glance Commentary
The ventilation (VE) vs. VCO2 relationship during exercise is
commonly used to assess ventilatory efficiency and prognosis in
heart failure patients. The slope of the VE vs. VCO2 relationship
increases as heart failure severity increases, whereas in respiratory
patients the VE vs. VCO2 slope during exercise is reduced the
greater the ventilatory limitation. However, respiratory disease
often coexists in heart failure patients so that the mean of the slope
of the VE vs. VCO2 relationship in these cases is unclear.
We reasoned that the VE vs. VCO2 behavior during exercise is
a linear relationship, at least up to the respiratory compensation
point, characterized by a slope and a Y intercept value. The latter
has been ignored, but it represent the ventilation at VOC2= 0 and
therefore it is somehow related to dead space ventilation.
Accordingly, we built a human model of increased anatomical
dead space, resembling what happens in chronic obstructive
pulmonary disease, by adding external dead space during exercise
in healthy subjects and HF patients. We demonstrated that adding
dead space increases the Y intercept of the VE vs. VCO2
relationship. The Y intercept of VE vs. VCO2 relationship is
suggested as an index of increased dead space ventilation so that
the finding of a elevated Y-intercept in a heart failure patient
should bring the suspicious of a coexisting respiratory disease.
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